HANCOCK JAFFE PE Ratio 2017-2018 | HJLI

Current and historical p/e ratio for HANCOCK JAFFE (HJLI) from 2017 to 2018. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. HANCOCK JAFFE PE ratio as of February 15, 2019 is 0.00.
HANCOCK JAFFE PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2019-02-15 1.59 inf
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.019B $0.000B
Hancock Jaffe Laboratories, Inc. is involved in developing and manufacturing bioprosthetic medical devices to treat cardiac and vascular diseases. Its product candidates consists of the porcine tissue based VenoValve, which is intended to be surgically implanted in the deep venous system of the leg to treat Chronic Venue Insufficiency; CoreoGraft?, a bovine tissue based off the shelf conduit intended to be used for coronary artery bypass surgery and a porcine tissue based heart valve, is an ideal candidate for pediatric aortic/mitral valve replacement. Hancock Jaffe Laboratories, Inc. is based in IRVINE, United States.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $44.807B 29.70
Takeda Pharmaceutical (TAK) Japan $31.419B 11.62
Grifols (GRFS) Spain $13.084B 15.86
Ionis Pharmaceuticals (IONS) United States $8.099B 0.00
Neurocrine Biosciences (NBIX) United States $7.679B 497.35
Jazz Pharmaceuticals (JAZZ) Ireland $7.560B 10.85
Sage Therapeutics (SAGE) United States $7.412B 0.00
Nektar Therapeutics (NKTR) United States $7.377B 10.58
Loxo Oncology (LOXO) United States $7.184B 0.00
Tilray (TLRY) United States $7.138B 0.00
Catalent (CTLT) United States $6.055B 25.35
United Therapeutics (UTHR) United States $5.167B 8.45
FibroGen (FGEN) United States $4.840B 0.00
Taro Pharmaceutical Industries (TARO) Israel $4.117B 13.25
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $3.953B 21.02
USANA Health Sciences (USNA) United States $2.562B 20.91
Endo (ENDP) Ireland $2.360B 3.62
Ironwood Pharmaceuticals (IRWD) United States $2.144B 0.00
Madrigal Pharmaceuticals (MDGL) United States $2.062B 0.00
Heron Therapeutics (HRTX) United States $2.044B 0.00
Portola Pharmaceuticals (PTLA) United States $1.980B 0.00
Zogenix (ZGNX) United States $1.975B 0.00
Xencor (XNCR) United States $1.972B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.886B 23.49
Aerie Pharmaceuticals (AERI) United States $1.867B 0.00
PTC Therapeutics (PTCT) United States $1.665B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $1.659B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.631B 220.44
Theravance Biopharma (TBPH) Cayman Islands $1.493B 0.00
TherapeuticsMD (TXMD) United States $1.363B 0.00
Corcept Therapeutics (CORT) United States $1.314B 19.29
Spectrum Pharmaceuticals (SPPI) United States $1.251B 0.00
Esperion Therapeutics (ESPR) United States $1.193B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.986B 0.00
Tricida (TCDA) United States $0.936B 0.00
ImmunoGen (IMGN) United States $0.819B 0.00
Radius Health (RDUS) United States $0.805B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.588B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.562B 0.00
ChemoCentryx (CCXI) United States $0.549B 43.44
Siga Technologies (SIGA) United States $0.542B 0.00
Flexion Therapeutics (FLXN) United States $0.537B 0.00
Karyopharm Therapeutics (KPTI) United States $0.535B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.495B 29.18
GlycoMimetics (GLYC) United States $0.494B 0.00
Forty Seven (FTSV) United States $0.479B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.466B 0.00
Collegium Pharmaceutical (COLL) United States $0.462B 0.00
Odonate Therapeutics (ODT) United States $0.446B 0.00
Aptorum Group (APM) China $0.429B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.378B 0.00
Akebia Therapeutics (AKBA) United States $0.369B 0.00
Lannett Co Inc (LCI) United States $0.367B 3.41
ArQule (ARQL) United States $0.351B 0.00
KalVista Pharmaceuticals (KALV) United States $0.338B 0.00
CASI Pharmaceuticals (CASI) United States $0.334B 0.00
Concert Pharmaceuticals (CNCE) United States $0.334B 0.00
Majesco Entertainment (PTE) United States $0.333B 0.00
Translate Bio (TBIO) United States $0.333B 0.00
Tyme Technologies (TYME) United States $0.323B 0.00
Dermira (DERM) United States $0.319B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.308B 0.00
Aclaris Therapeutics (ACRS) United States $0.305B 0.00
OptiNose (OPTN) United States $0.295B 0.00
Minerva Neurosciences (NERV) United States $0.282B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.279B 10.38
Catalyst Pharmaceuticals (CPRX) United States $0.278B 0.00
Mast Therapeutics (SVRA) United States $0.244B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.242B 0.00
Opexa Therapeutics (ACER) United States $0.227B 0.00
IMV INC (IMV) Canada $0.225B 0.00
Affimed (AFMD) Germany $0.217B 0.00
Dova Pharmaceuticals (DOVA) United States $0.214B 0.00
MEI Pharma (MEIP) United States $0.210B 0.00
Aratana Therapeutics (PETX) United States $0.210B 0.00
Aldeyra Therapeutics (ALDX) United States $0.209B 0.00
Rafael Holdings (RFL) United States $0.207B 0.00
ElectroCore (ECOR) United States $0.206B 0.00
Galectin Therapeutics (GALT) United States $0.204B 0.00
Calithera Biosciences (CALA) United States $0.199B 0.00
Xeris Pharmaceuticals (XERS) United States $0.192B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.192B 0.00
Taiwan Liposome, Unsponsored ADR (TLC) Taiwan $0.189B 0.00
Recro Pharma (REPH) United States $0.184B 0.00
Redhill Biopharma (RDHL) Israel $0.179B 0.00
Molecular Templates (MTEM) United States $0.165B 0.00
Zafgen (ZFGN) United States $0.164B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.163B 0.00
Nature's Sunshine Products (NATR) United States $0.160B 0.00
Aquestive Therapeutics (AQST) United States $0.160B 0.00
Ardelyx (ARDX) United States $0.157B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.156B 0.00
AgeX Therapeutics (AGE) United States $0.155B 0.00
Ocular Therapeutix (OCUL) United States $0.152B 0.00
Adherex Technologies (FENC) United States $0.148B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.148B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.147B 0.00
Jounce Therapeutics (JNCE) United States $0.141B 0.00
Neon Therapeutics (NTGN) United States $0.140B 0.00
Cardiome Pharma (CORV) Canada $0.137B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.136B 0.00
MediWound (MDWD) Israel $0.127B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.119B 0.00
China SXT Pharmaceuticals (SXTC) China $0.118B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.117B 0.00
ProNAi Therapeutics (SRRA) Canada $0.115B 0.00
DURECT (DRRX) United States $0.112B 0.00
Champions Oncology (CSBR) United States $0.111B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.100B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.091B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.088B 0.00
Iterum Therapeutics (ITRM) Ireland $0.084B 0.00
Melinta Therapeutics (MLNT) United States $0.083B 0.00
Natural Alternatives (NAII) United States $0.080B 7.80
Infinity Pharmaceuticals (INFI) United States $0.077B 0.00
Nivalis Therapeutics (ALPN) United States $0.077B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.073B 0.00
Immune Design (IMDZ) United States $0.070B 0.00
Synergy Pharmaceuticals (SGYP) United States $0.070B 0.00
Neos Therapeutics (NEOS) United States $0.068B 0.00
Forward Pharma (FWP) Denmark $0.068B 0.00
Zomedica Pharmaceuticals (ZOM) United States $0.066B 0.00
SCYNEXIS (SCYX) United States $0.066B 0.00
Achaogen (AKAO) United States $0.065B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.064B 0.00
Avenue Therapeutics (ATXI) United States $0.063B 0.00
KemPharm (KMPH) United States $0.062B 0.00
Otonomy (OTIC) United States $0.062B 0.00
Ampio Pharmaceuticals (AMPE) United States $0.062B 0.00
Actinium Pharmaceuticals (ATNM) United States $0.061B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.056B 0.00
CTI BioPharma (CTIC) United States $0.053B 0.00
Mannatechorporated (MTEX) United States $0.046B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.045B 0.00
Genocea Biosciences (GNCA) United States $0.043B 0.00
BioLineRx (BLRX) Israel $0.043B 0.00
Tokai Pharmaceuticals (NVUS) United States $0.040B 0.00
Capnia (SLNO) United States $0.036B 0.00
ProPhase Labs (PRPH) United States $0.035B 0.00
Lipocine (LPCN) United States $0.035B 0.00
ContraFect (CFRX) United States $0.034B 0.00
Heat Biologics (HTBX) United States $0.033B 0.00
NOVAN INC (NOVN) United States $0.032B 0.00
NanoViricides (NNVC) United States $0.029B 0.00
IsoRay (ISR) United States $0.026B 0.00
PharmAthene (ALT) United States $0.026B 0.00
Biomerica (BMRA) United States $0.024B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.024B 0.00
Can-Fite Biopharma (CANF) Israel $0.023B 0.00
ESSA Pharma (EPIX) Canada $0.023B 0.00
Xenetic Biosciences (XBIO) United States $0.020B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.020B 0.00
Trillium Therapeutics (TRIL) Canada $0.019B 0.00
Pain Therapeutics (PTIE) United States $0.019B 0.00
Citius Pharmaceuticals (CTXR) United States $0.019B 0.00
Cyanotech (CYAN) United States $0.019B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.018B 0.00
Onconova Therapeutics (ONTX) United States $0.018B 0.00
CollPlant Holdings Sponsored ADR (CLGN) Israel $0.018B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.018B 0.00
Jaguar Animal Health (JAGX) United States $0.016B 0.00
Auris Medical Holding AG (EARS) Switzerland $0.014B 0.00
VAXART, INC (VXRT) United States $0.014B 0.00
PRECISION THERAPEUTICS INC (AIPT) United States $0.014B 0.00
OncoGenex Pharmaceuticals (ACHV) United States $0.012B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.012B 0.00
Shineco (TYHT) China $0.011B 1.15
DelMar Pharmaceuticals (DMPI) Canada $0.010B 0.00
Regulus Therapeutics (RGLS) United States $0.009B 0.00
RXi Pharmaceuticals (PHIO) United States $0.007B 0.00
Intellipharmaceutics (IPCI) Canada $0.006B 0.00
Ohr Pharmaceuticals (OHRP) United States $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Bio Blast Pharma (ORPN) Israel $0.004B 0.00
Ritter Pharmaceuticals (RTTR) United States $0.004B 0.00
Midatech Pharma (MTP) United Kingdom $0.003B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.003B 0.00
Bio-Path Holdings (BPTH) United States $0.001B 0.00
Advanced Accelerator Applications (AAAP) France $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00